87 related articles for article (PubMed ID: 30937530)
21. Diffuse leptomeningeal glioneuronal tumour (DLGNT) with hydrocephalus as an initial symptom: a case-based update.
Chen W; Kong Z; Fu J; Zhao D; Wang R; Ma W; Wang Y
Childs Nerv Syst; 2020 Mar; 36(3):459-468. PubMed ID: 31897629
[TBL] [Abstract][Full Text] [Related]
22. Contemporary outcomes of diffuse leptomeningeal glioneuronal tumor in pediatric patients: A case series and literature review.
Lu VM; Di L; Gernsback J; Eichberg DG; Luther EM; Shah AH; Daniels DJ; Maher OM; Niazi TN
Clin Neurol Neurosurg; 2022 Jul; 218():107265. PubMed ID: 35567835
[TBL] [Abstract][Full Text] [Related]
23. A germline variant of TP53 in paediatric diffuse leptomeningeal glioneuronal tumour.
Tan GIL; Merchant K; Tan EEK; Low DCY; Ng LP; Seow WT; Low SYY
Childs Nerv Syst; 2019 Jun; 35(6):1021-1027. PubMed ID: 30937530
[TBL] [Abstract][Full Text] [Related]
24. Adult diffuse leptomeningeal glioneuronal tumour with limited leptomeningeal involvement, lack of 1p deletion and BRAF V600E mutation.
Gai D; Christie M; Gaillard F
J Clin Neurosci; 2020 Sep; 79():215-218. PubMed ID: 33070899
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation array analysis for diffuse leptomeningeal glioneuronal tumor with conspicuous hypothalamic mass. A case report.
Yamada S; Tanikawa M; Shibata H; Honda-Kitahara M; Nakano Y; Satomi K; Sakata T; Hirose T; Ichimura K; Mase M
Neuropathology; 2022 Dec; 42(6):512-518. PubMed ID: 36071620
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in diffuse leptomeningeal glioneuronal tumor (DLGNT): a systematic review.
Wiśniewski K; Brandel MG; Gonda DD; Crawford JR; Levy ML
Childs Nerv Syst; 2022 Sep; 38(9):1663-1673. PubMed ID: 35867118
[TBL] [Abstract][Full Text] [Related]
27. Atypical clinical presentation mimicking stroke in an adult patient caused by a rare diffuse leptomeningeal glioneuronal tumour.
Stapińska-Syniec A; Gogol A; Acewicz A; Sobstyl M; Wierzba-Bobrowicz T; Grajkowska W
Pol J Pathol; 2022; 73(4):371-375. PubMed ID: 36946275
[TBL] [Abstract][Full Text] [Related]
28. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.
Deng MY; Sill M; Chiang J; Schittenhelm J; Ebinger M; Schuhmann MU; Monoranu CM; Milde T; Wittmann A; Hartmann C; Sommer C; Paulus W; Gärtner J; Brück W; Rüdiger T; Leipold A; Jaunmuktane Z; Brandner S; Giangaspero F; Nozza P; Mora J; Morales la Madrid A; Cruz Martinez O; Hansford JR; Pietsch T; Tietze A; Hernáiz-Driever P; Stoler I; Capper D; Korshunov A; Ellison DW; von Deimling A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2018 Aug; 136(2):239-253. PubMed ID: 29766299
[TBL] [Abstract][Full Text] [Related]
29. Clinical responses of patients with diffuse leptomeningeal glioneuronal tumors to chemotherapy.
Aguilera D; Castellino RC; Janss A; Schniederjan M; McNall R; MacDonald T; Mazewski C
Childs Nerv Syst; 2018 Feb; 34(2):329-334. PubMed ID: 28965234
[TBL] [Abstract][Full Text] [Related]
30. Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies.
Goodman AM; Choi M; Wieduwilt M; Mulroney C; Costello C; Frampton G; Miller V; Kurzrock R
JCO Precis Oncol; 2017 Jun; 1():. PubMed ID: 28681041
[TBL] [Abstract][Full Text] [Related]
31. Newly Identified Characteristics and Suggestions for Diagnosis and Treatment of Diffuse Leptomeningeal Glioneuronal/Neuroepithelial Tumors: A Case Report and Review of the Literature.
Lyle MR; Dolia JN; Fratkin J; Nichols TA; Herrington BL
Child Neurol Open; 2015; 2(1):2329048X14567531. PubMed ID: 28503587
[TBL] [Abstract][Full Text] [Related]
32. Diffuse leptomeningeal glioneuronal tumor (DLGNT) mimicking Whipple's disease: a case report and literature review.
Karlowee V; Kolakshyapati M; Amatya VJ; Takayasu T; Nosaka R; Sugiyama K; Kurisu K; Yamasaki F
Childs Nerv Syst; 2017 Aug; 33(8):1411-1414. PubMed ID: 28382437
[TBL] [Abstract][Full Text] [Related]
33. Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine.
Dupain C; Harttrampf AC; Urbinati G; Geoerger B; Massaad-Massade L
Mol Ther Nucleic Acids; 2017 Mar; 6():315-326. PubMed ID: 28325298
[TBL] [Abstract][Full Text] [Related]
34. Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade.
Johnson DB; Frampton GM; Rioth MJ; Yusko E; Xu Y; Guo X; Ennis RC; Fabrizio D; Chalmers ZR; Greenbowe J; Ali SM; Balasubramanian S; Sun JX; He Y; Frederick DT; Puzanov I; Balko JM; Cates JM; Ross JS; Sanders C; Robins H; Shyr Y; Miller VA; Stephens PJ; Sullivan RJ; Sosman JA; Lovly CM
Cancer Immunol Res; 2016 Nov; 4(11):959-967. PubMed ID: 27671167
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
